University Musculoskeletal Oncology Unit, Mount Sinai Hospital, University of Toronto, Toronto, Canada.
Department of Software Engineering, ORT Braude Academic College, Karmiel, Israel.
Ann Surg Oncol. 2023 Jun;30(6):3701-3711. doi: 10.1245/s10434-023-13261-5. Epub 2023 Feb 25.
Resection of soft-tissue sarcomas from the adductor compartment is associated with significant complications. Free/pedicled flaps often are used for wound closure, but their effect on healing is unclear. We compared wound complications, oncologic, and functional outcomes for patients undergoing flap reconstruction or primary closure following resection of adductor sarcomas.
A total of 177 patients underwent resection of an adductor sarcoma with primary closure (PrC) or free/pedicled flap reconstruction (FR). Patient, tumor, and treatment characteristics were compared, as well as wound complications, oncologic, and functional outcomes (TESS/MSTS87/MSTS93). To examine the relative benefit of flap reconstruction, number needed to treat (NNT) was calculated.
In total, 143 patients underwent PrC and 34 had FR, 68% of which were pedicled. There were few differences in demographic, tumor, or treatment characteristics. No significant difference was found in the rate of wound complications. Length of stay was significantly longer in FR (18 days vs. PrC 8 days; p < 0.01). Oncologic and functional outcomes were similar over 5 years follow-up. Uncomplicated wound healing occurred more often in FR compared with PrC for tumors with ≥15 cm (NNT = 8.4) or volumes ≥ 800 ml (NNT = 8.4). Tumors ≤ 336 ml do not benefit from a flap, whereas those > 600 ml are 1.5 times more likely to heal uneventfully after flap closure.
Although flap use prolonged hospitalization, it decreased wound healing complications for larger tumors, and in all sized tumors, it demonstrated similar functional and oncologic outcomes to primary closure. Our size-based treatment criteria can help to identify patients with large adductor sarcomas who could benefit from flap reconstruction.
(Retrospective cohort study).
切除内收肌软组织肉瘤会引起严重的并发症。游离/带蒂皮瓣常被用于关闭伤口,但它们对愈合的影响尚不清楚。我们比较了接受内收肌肉瘤切除后行皮瓣重建或一期缝合的患者的伤口并发症、肿瘤学和功能结局。
共 177 例患者接受了内收肌肉瘤切除术,其中 143 例行一期缝合(PrC),34 例行游离/带蒂皮瓣重建(FR)。比较了患者、肿瘤和治疗特征,以及伤口并发症、肿瘤学和功能结局(TESS/MSTS87/MSTS93)。为了检验皮瓣重建的相对益处,计算了需要治疗的数量(NNT)。
共 143 例行 PrC,34 例行 FR,其中 68%为带蒂皮瓣。患者的人口统计学、肿瘤和治疗特征差异较小。两组的伤口并发症发生率无显著差异。FR 的住院时间明显更长(18 天 vs. PrC 8 天;p < 0.01)。5 年随访时,肿瘤学和功能结局相似。对于直径≥15cm(NNT=8.4)或体积≥800ml(NNT=8.4)的肿瘤,FR 中无并发症的伤口愈合更常见。体积≤336ml 的肿瘤从皮瓣中获益不大,而体积>600ml 的肿瘤皮瓣闭合后无并发症愈合的可能性增加 1.5 倍。
尽管皮瓣使用延长了住院时间,但对于较大的肿瘤,它降低了伤口愈合并发症的发生率,并且在所有大小的肿瘤中,它与一期缝合相比具有相似的功能和肿瘤学结局。我们基于体积的治疗标准可以帮助识别可能受益于皮瓣重建的大型内收肌肉瘤患者。
证据水平 III:(回顾性队列研究)。